These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 29458204

  • 1. A review of implantable biosensors for closed-loop glucose control and other drug delivery applications.
    Scholten K, Meng E.
    Int J Pharm; 2018 Jun 15; 544(2):319-334. PubMed ID: 29458204
    [Abstract] [Full Text] [Related]

  • 2. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
    Renard E.
    Curr Opin Pharmacol; 2002 Dec 15; 2(6):708-16. PubMed ID: 12482735
    [Abstract] [Full Text] [Related]

  • 3. Advances in bioresponsive closed-loop drug delivery systems.
    Yu J, Zhang Y, Yan J, Kahkoska AR, Gu Z.
    Int J Pharm; 2018 Jun 15; 544(2):350-357. PubMed ID: 29191483
    [Abstract] [Full Text] [Related]

  • 4. Closed loop insulin delivery in diabetes.
    Battelino T, Omladič JŠ, Phillip M.
    Best Pract Res Clin Endocrinol Metab; 2015 Jun 15; 29(3):315-25. PubMed ID: 26051293
    [Abstract] [Full Text] [Related]

  • 5. Integration of biosensors and drug delivery technologies for early detection and chronic management of illness.
    Ngoepe M, Choonara YE, Tyagi C, Tomar LK, du Toit LC, Kumar P, Ndesendo VM, Pillay V.
    Sensors (Basel); 2013 Jun 14; 13(6):7680-713. PubMed ID: 23771157
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological aspects of closed loop insulin delivery for type 1 diabetes.
    Uduku C, Oliver N.
    Curr Opin Pharmacol; 2017 Oct 14; 36():29-33. PubMed ID: 28802779
    [Abstract] [Full Text] [Related]

  • 7. Implantable continuous glucose sensors.
    Renard E.
    Curr Diabetes Rev; 2008 Aug 14; 4(3):169-74. PubMed ID: 18690897
    [Abstract] [Full Text] [Related]

  • 8. Towards smart tattoos: implantable biosensors for continuous glucose monitoring.
    Heo YJ, Takeuchi S.
    Adv Healthc Mater; 2013 Jan 14; 2(1):43-56. PubMed ID: 23184404
    [Abstract] [Full Text] [Related]

  • 9. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D, Biagioni M, Allen JM, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska ME, Haidar A, Calhoun P, Kollman C, Jackson NC, Umpleby AM, Acerini CL, Dunger DB, Hovorka R.
    Diabetes Obes Metab; 2015 Dec 14; 17(12):1173-9. PubMed ID: 26257323
    [Abstract] [Full Text] [Related]

  • 10. Amperometric glucose sensors: sources of error and potential benefit of redundancy.
    Castle JR, Ward WK.
    J Diabetes Sci Technol; 2010 Jan 01; 4(1):221-5. PubMed ID: 20167187
    [Abstract] [Full Text] [Related]

  • 11. [From external to implantable insulin pump, can we close the loop?].
    Renard E, Costalat G, Bringer J.
    Diabetes Metab; 2002 Sep 01; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
    [Abstract] [Full Text] [Related]

  • 12. Wearable Glucose Monitoring and Implantable Drug Delivery Systems for Diabetes Management.
    Zhang J, Xu J, Lim J, Nolan JK, Lee H, Lee CH.
    Adv Healthc Mater; 2021 Sep 01; 10(17):e2100194. PubMed ID: 33930258
    [Abstract] [Full Text] [Related]

  • 13. [Research Progress of Implantable Biosensors for Continuous Glucose Monitoring].
    Yu J, Li Z, Chen C, Chen Y, Zhu Z.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Oct 01; 33(5):991-7. PubMed ID: 29714956
    [Abstract] [Full Text] [Related]

  • 14. Continuous glucose monitoring and closed-loop systems.
    Hovorka R.
    Diabet Med; 2006 Jan 01; 23(1):1-12. PubMed ID: 16409558
    [Abstract] [Full Text] [Related]

  • 15. In vivo glucose monitoring: towards 'Sense and Act' feedback-loop individualized medical systems.
    Wang J.
    Talanta; 2008 May 15; 75(3):636-41. PubMed ID: 18585125
    [Abstract] [Full Text] [Related]

  • 16. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC.
    Diabetes Technol Ther; 2011 Jul 15; 13(7):695-8. PubMed ID: 21668344
    [No Abstract] [Full Text] [Related]

  • 17. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD, Wysocki T, Thabit H, Evans ML, Amiel S, Heller S, Young A, Hovorka R, Angela Consortium.
    Diabet Med; 2015 May 15; 32(5):601-8. PubMed ID: 25615888
    [Abstract] [Full Text] [Related]

  • 18. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R, Danne T, Kordonouri O, Atlas E, Bratina N, Biester T, Avbelj M, Miller S, Muller I, Phillip M, Battelino T.
    Pediatr Diabetes; 2013 May 15; 14(3):159-67. PubMed ID: 23448393
    [Abstract] [Full Text] [Related]

  • 19. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
    Elleri D, Allen JM, Nodale M, Wilinska ME, Mangat JS, Larsen AM, Acerini CL, Dunger DB, Hovorka R.
    Diabetes Technol Ther; 2011 Apr 15; 13(4):419-24. PubMed ID: 21355719
    [Abstract] [Full Text] [Related]

  • 20. Diabetes technology and treatments in the paediatric age group.
    Shalitin S, Peter Chase H.
    Int J Clin Pract Suppl; 2011 Feb 15; (170):76-82. PubMed ID: 21323816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.